VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 634 filers reported holding VANECK VECTORS ETF TR in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $942,307 | +74.8% | 35,017 | +95.6% | 0.01% | +40.0% |
| Q2 2023 | $538,969 | -6.9% | 17,900 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $579,065 | +9.8% | 17,900 | -2.7% | 0.01% | 0.0% |
| Q4 2022 | $527,344 | +18.8% | 18,400 | 0.0% | 0.01% | +20.0% |
| Q3 2022 | $444,000 | -11.9% | 18,400 | 0.0% | 0.01% | -16.7% |
| Q2 2022 | $504,000 | -39.8% | 18,400 | -15.7% | 0.01% | -33.3% |
| Q1 2022 | $837,000 | +55.3% | 21,830 | +29.7% | 0.01% | +80.0% |
| Q4 2021 | $539,000 | +8.7% | 16,830 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $496,000 | -13.3% | 16,830 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $572,000 | -0.7% | 16,830 | -5.0% | 0.01% | -14.3% |
| Q1 2021 | $576,000 | -9.7% | 17,720 | 0.0% | 0.01% | -22.2% |
| Q4 2020 | $638,000 | -7.0% | 17,720 | +1.1% | 0.01% | -25.0% |
| Q3 2020 | $686,000 | +25.9% | 17,530 | +18.0% | 0.01% | +9.1% |
| Q2 2020 | $545,000 | +64.7% | 14,860 | +3.5% | 0.01% | +10.0% |
| Q1 2020 | $331,000 | -47.0% | 14,360 | -32.8% | 0.01% | -37.5% |
| Q4 2019 | $625,000 | +9.5% | 21,360 | 0.0% | 0.02% | 0.0% |
| Q3 2019 | $571,000 | +5.0% | 21,360 | +0.4% | 0.02% | -5.9% |
| Q2 2019 | $544,000 | +14.8% | 21,280 | +0.7% | 0.02% | +6.2% |
| Q1 2019 | $474,000 | +6.3% | 21,130 | 0.0% | 0.02% | -5.9% |
| Q4 2018 | $446,000 | +14.1% | 21,130 | 0.0% | 0.02% | +30.8% |
| Q3 2018 | $391,000 | -17.0% | 21,130 | 0.0% | 0.01% | -27.8% |
| Q2 2018 | $471,000 | -25.8% | 21,130 | -26.9% | 0.02% | -30.8% |
| Q1 2018 | $635,000 | +39.9% | 28,911 | +48.0% | 0.03% | +44.4% |
| Q4 2017 | $454,000 | -53.1% | 19,531 | -53.6% | 0.02% | -57.1% |
| Q3 2017 | $967,000 | +120.8% | 42,131 | +112.5% | 0.04% | +110.0% |
| Q2 2017 | $438,000 | -4.6% | 19,831 | -1.5% | 0.02% | -4.8% |
| Q1 2017 | $459,000 | +6.2% | 20,139 | -2.5% | 0.02% | -4.5% |
| Q4 2016 | $432,000 | -16.9% | 20,664 | +5.1% | 0.02% | -18.5% |
| Q3 2016 | $520,000 | -47.8% | 19,664 | -45.3% | 0.03% | -50.9% |
| Q2 2016 | $996,000 | – | 35,943 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |